PR PolyResearch

Join Free

NASDAQ

Zions Bancorporation N.A. (ZION)

♥ 657 Thanks from members

Zions Bancorporation N.A. (ZION) demonstrated robust second-quarter 2026 earnings with a notable beat driven by equity investment gains and stable net interest margins, though rising costs prompted a cautious downgrade from JPMorgan.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)